Aberrant expression of the glycoprotein mucin-1 (MUC1) has been associated with pancreatic cancer progression and metastasis as a result of mediating the oncogenic transcriptional regulation of target genes. In the present study, we demonstrate that MUC1 downregulates the expression of the tumor suppressor polypeptide N-acetylgalactosaminyltransferase 5 in pancreatic cancer. ChIP-on-chip analysis revealed that the MUC1 cytoplasmic tail binds to regulatory elements in the GALNT5 gene. Additionally, MUC1 increases binding of p53 and c-Jun and decreases the binding of Sp1 to the proximal promoter and exonic regions of GALNT5. We also observed that expression of N-acetylgalactosaminyltransferase 5 is inversionally proportional to MUC1 expression in human pancreatic cancer. These results demonstrate that MUC1 downregulates the expression of N-acetylgalactosaminyltransferase 5 in pancreatic cancer by modifying the promoter occupancy of transcription factors through its cytoplasmic domain.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048170PMC
http://dx.doi.org/10.1002/1873-3468.13532DOI Listing

Publication Analysis

Top Keywords

pancreatic cancer
20
glycoprotein mucin-1
8
demonstrate muc1
8
muc1 downregulates
8
downregulates expression
8
n-acetylgalactosaminyltransferase pancreatic
8
expression n-acetylgalactosaminyltransferase
8
expression
6
muc1
6
pancreatic
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!